Ochre Bio
RNA medicines for liver diseases
Oxford, United Kingdom · Founded 2019
- Headquarters
- Oxford
- Employees
- 11–50
- Founded
- 2019
- Website
- ochre-bio.com
- Last Round
- Series AOct 2022
- Rounds
- 2
About
Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.
Summary
Ochre Bio is a Biotech company based in Oxford, United Kingdom, founded in 2019. Its most recent funding was a Series A round in Oct 2022. Investors include Khosla Ventures, Backed and Lifeforce Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company